These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2521935)

  • 21. [Acinetobacter, a nosocomial pathogen. Contribution of experimental models].
    Joly-Guillou ML; Hidri N; Wolff M
    Presse Med; 2002 Apr; 31(14):651-6. PubMed ID: 11995384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concerning the sensitivity of Acinetobacter calcoaceticus.
    Jedlicková Z; Tesaríková E; Výmola F
    J Hyg Epidemiol Microbiol Immunol; 1990; 34(1):73-6. PubMed ID: 2351822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study on the resistant genes to carbapenems and epidemiological characterization of multidrug-resistant Acinetobacter baumannii isolates.
    Jiang W; Liu H; Zhong M; Yang YC; Xiao DW; Huang WF
    Microb Drug Resist; 2013 Apr; 19(2):117-23. PubMed ID: 22845773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiologic characterization of nosocomial Acinetobacter baumannii infections in a Turkish university hospital by pulsed-field gel electrophoresis.
    Cetin ES; Durmaz R; Tetik T; Otlu B; Kaya S; Calişkan A
    Am J Infect Control; 2009 Feb; 37(1):56-64. PubMed ID: 18834735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative activity of imipenem, ceftazidime and cefotaxime against Acinetobacter calcoaceticus].
    Vallée E; Joly-Guillou ML; Bergogne-Berezin E
    Presse Med; 1990 Apr; 19(13):588-91. PubMed ID: 2139937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Bacteriologic and clinical analysis of nosocomial infections in patients from the intensive care unit].
    Nikodemski T
    Ann Acad Med Stetin; 1999; 45():211-26. PubMed ID: 10909491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and in-vitro antimicrobial susceptibility patterns of Acinetobacter strains isolated from patients in intensive care units.
    Aktas O; Ozbek A
    J Int Med Res; 2003; 31(4):272-80. PubMed ID: 12964502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acinetobacter calcoaceticus variety anitratus: an increasing nosocomial problem.
    Ramphal R; Kluge RM
    Am J Med Sci; 1979; 277(1):57-66. PubMed ID: 426000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiological characteristics and drug resistance analysis of multidrug-resistant Acinetobacter baumannii in a China hospital at a certain time.
    Jiang M; Zhang Z; Zhao S
    Pol J Microbiol; 2014; 63(3):275-81. PubMed ID: 25546937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The increasing significance of outbreaks of Acinetobacter spp.: the need for control and new agents.
    Bergogne-Bérézin E
    J Hosp Infect; 1995 Jun; 30 Suppl():441-52. PubMed ID: 7560983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between antibiotic usage and subsequent colonization or infection of extensive drug-resistant Acinetobacter baumannii: a matched case-control study in intensive care units.
    Tsai HT; Wang JT; Chen CJ; Chang SC
    Diagn Microbiol Infect Dis; 2008 Nov; 62(3):298-305. PubMed ID: 18707839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [In vitro activity of ceftazidime compared with five beta-lactamase stable compounds against clinical strains of Acinetobacter calcoaceticus ].
    Bergogne-Berezin E; Joly-Guillou ML; Verin-Prevost C
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):506-9. PubMed ID: 6289227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nosocomial outbreaks due to amikacin-resistant tobramycin-sensitive Acinetobacter species: correlation with amikacin usage.
    Buisson Y; Tran Van Nhieu G; Ginot L; Bouvet P; Schill H; Driot L; Meyran M
    J Hosp Infect; 1990 Jan; 15(1):83-93. PubMed ID: 1968483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species.
    Paterson DL
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S43-8. PubMed ID: 16894514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evolution of antimicrobial susceptibility of Acinetobacter baumannii clinical isolates].
    López-Hernández S; Alarcón T; López-Brea M
    Rev Esp Quimioter; 2000 Dec; 13(4):394-400. PubMed ID: 11498706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and epidemiological features of an outbreak of acinetobacter infection in an intensive therapy unit.
    Crowe M; Towner KJ; Humphreys H
    J Med Microbiol; 1995 Jul; 43(1):55-62. PubMed ID: 7608957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evolution of Acinetobacter calcoaceticus in the hospital milieu, from 1971 to 1984].
    Joly-Guillou ML; Bergogne-Berezin E
    Presse Med; 1985 Dec; 14(46):2331-5. PubMed ID: 2935831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A study of the relationships between antibiotic resistance phenotypes, phage-typing and biotyping of 117 clinical isolates of Acinetobacter spp.
    Joly-Guillou ML; Bergogne-Berezin E; Vieu JF
    J Hosp Infect; 1990 Jul; 16(1):49-58. PubMed ID: 1974906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [In vitro activity of 9 antibiotics and 3 beta-lactamase inhibitors against 107 clinical isolates of Acinetobacter baumanii].
    Echeverría MJ; López de Goicoechea MJ; Ayarza R; Vecino Y; Lazpita MA; Ibarretxebea AB; Barbier A; Cruz González M; Martínez de la Fuente P
    Enferm Infecc Microbiol Clin; 1997; 15(6):319-22. PubMed ID: 9376404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phage-types and susceptibility to 26 antibiotics of nosocomial strains of Acinetobacter isolated in Portugal.
    Santos Ferreira MO; Vieu JF; Klein B
    J Int Med Res; 1984; 12(6):364-8. PubMed ID: 6519351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.